Get the Stockscreener App
7.63
5.68%
0.41
After Hours:
7.78
0.15
+1.97%
Lifecore Biomedical Inc stock is traded at $7.63, with a volume of 113.45K.
It is up +5.68% in the last 24 hours and down -8.07% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$7.22
Open:
$7.33
24h Volume:
113.45K
Relative Volume:
0.58
Market Cap:
$285.42M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
152.60
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
+5.24%
1M Performance:
-8.07%
6M Performance:
+33.39%
1Y Performance:
+40.52%
1-Day Range:
$7.1251
$7.675
1-Week Range:
$7.03
$7.86
52-Week Range:
$3.6793
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.63 | 267.32M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
149.77 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.63 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.58 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.60 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.39 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
Volume spikes in Lifecore Biomedical Inc. stock – what they meanWeekly Growth Portfolio Performance Summary - Newser
What to expect from Lifecore Biomedical Inc. in the next 30 daysFree Entry Alert With Low Drawdown Strategy - Newser
Should you hold or exit Lifecore Biomedical Inc. nowShort Squeeze Opportunities with Indicators - Newser
Short interest data insights for Lifecore Biomedical Inc.Quarterly Investment Outlook and Key Summary - Newser
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Using Ichimoku Cloud for Lifecore Biomedical Inc. technicalsTechnical Insight Guide for Safer Trades - Newser
Custom strategy builders for tracking Lifecore Biomedical Inc.Daily Market Movers Screener with Filters - Newser
Lifecore Biomedical Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingPredictable Return Strategy with AI Support - Newser
Lifecore Biomedical Exceeds Revenue Estimates, Reports Q4 $36.4M and EPS Loss of $0.06 - AInvest
Lifecore Biomedical 2025 Q4 Earnings Significant Net Loss Improvement - AInvest
Lifecore (LFCR) Q4 Revenue Beats 3% - AOL.com
Lifecore Biomedical shares fall 3.61% intraday despite reporting $128.9 million in fiscal 2025 revenue. - AInvest
Lifecore Biomedical: Navigating Headwinds with Strategic Resilience and Long-Term Growth Catalysts - AInvest
Lifecore Biomedical's Q4 2025: Unpacking Key Contradictions on Tariffs, Demand, and Market Growth - AInvest
The one-year returns have been decent for Lifecore Biomedical (NASDAQ:LFCR) shareholders despite underlying losses increasing - simplywall.st
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss - Investing.com Nigeria
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss By Investing.com - Investing.com South Africa
Lifecore Biomedical: Fiscal Q4 Earnings Snapshot - Connecticut Post
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Lifecore Biomedical Inc reports results for the quarter ended May 31Earnings Summary - TradingView
Transcript : Lifecore Biomedical, Inc., Q4 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Signal strength of Lifecore Biomedical Inc. stock in tech scannersPredictable Income Summary for Long-Term Trades - Newser
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates - sharewise.com
Lifecore Biomedical’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating - TipRanks
Lifecore Biomedical earnings missed by $0.02, revenue topped estimates - Investing.com Canada
Lifecore Biomedical reports $128.9mln FY25 revenue, meets full-year guidance. - AInvest
Lifecore Biomedical Reports Q4 and FY25 Financial Results, Achieves Full-Year Guidance, and Provides Corporate Update - AInvest
India's Auto Component Industry Faces Challenges Amid US Tariffs, Calls for Enhanced Competitiveness and Diversification - AInvest
Laughing Water Capital's Top 5 Positions For Q2 2025 - Seeking Alpha
Lifecore Biomedical Reports 2025 Financial Results - TipRanks
Momentum divergence signals in Lifecore Biomedical Inc. chartFree Early Entry Tips With Low Risk Zone - Newser
How hedge fund analytics apply to Lifecore Biomedical Inc. stockBreakout Monitoring with Momentum Analysis - Newser
Ranking Lifecore Biomedical Inc. among high performing stocks via toolsPortfolio Review Summary with Five-Year Outlook - Newser
Can Lifecore Biomedical Inc. stock recover from recent declineDay Trading Setup Forecast with Trend Model - Newser
Lifecore Biomedical Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
What drives Lifecore Biomedical Inc. stock priceBuild a diversified portfolio for stability - Jammu Links News
What catalysts could drive Lifecore Biomedical Inc. stock higher in 2025Rapid return acceleration - Jammu Links News
What institutional investors are buying Lifecore Biomedical Inc. stockInvest confidently with professional market insights - Jammu Links News
What is the risk reward ratio of investing in Lifecore Biomedical Inc. stockInvest smarter with actionable stock recommendations - Jammu Links News
When is Lifecore Biomedical Inc. stock expected to show significant growthAchieve remarkable returns with smart investing - Jammu Links News
Is it the right time to buy Lifecore Biomedical Inc. stockCapitalize on momentum stocks early - Jammu Links News
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):